Absence of complement component 3 does not prevent classical pathway-mediated hemolysis.

Zhang, Lingjun; Dai, Yang; Huang, Ping; Saunders, Thomas L; Fox, David A; Xu, Jijun; Lin, Feng

Zhang, Lingjun; Dai, Yang; Huang, Ping; Saunders, Thomas L; Fox, David A; Xu, Jijun; Lin, Feng.

Afiliación

Zhang L; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Dai Y; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Huang P; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Saunders TL; Transgenic Animal Model Core and.
Fox DA; Division of Rheumatology, University of Michigan, Ann Arbor, MI; and.
Xu J; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Lin F; Department of Pain Management, Anesthesiology Institute, and.

Blood Adv ; 3(12): 1808-1814, 2019 06 25.

Article en En | MEDLINE | ID: mdl-31196848

Asunto(s)

Convertasas de Complemento C3-C5/metabolismo; Complemento C3/metabolismo; Complemento C5/metabolismo; Hemólisis/inmunología; Animales; Complemento C3/antagonistas & inhibidores; Complemento C3/uso terapéutico; Complemento C5/efectos de los fármacos; Femenino; Hemólisis/efectos de los fármacos; Humanos; Masculino; Modelos Animales; Ratas

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Complemento C3 / Complemento C5 / Convertasas de Complemento C3-C5 / Hemólisis Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google